UK/US - Biotechnology firm Sygen is abandoning its legal action against Watson Wyatt over "inappropriate" advice on setting up the firm's pension scheme.
The US-based firm’s decision will come as great relief to the consultant which could have triggered similar claims in the UK. Sygen set up its scheme after the firm split from previous owner Dalge...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here

